# Minnesota RETAIN Phase 2 (Sub-study)

> **NCT05216016** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 5200 (estimated)

## Conditions studied

- Injuries Related Work
- Illness Related Work
- Disability

## Interventions

- **OTHER:** RETAIN Program

## Key facts

- **NCT ID:** NCT05216016
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-23
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 5200 (ESTIMATED)
- **Last updated:** 2025-10-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05216016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05216016, "Minnesota RETAIN Phase 2 (Sub-study)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05216016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*